What is ConcertoCare?
ConcertoCare operates as a leading risk-bearing provider, specializing in the delivery of complex care for the most vulnerable and frail patient populations. By deploying multidisciplinary teams directly into the patient's environment, the company effectively bridges the gap between traditional clinical settings and home-based care. This model is designed to improve health outcomes while simultaneously lowering costs for payers and provider networks. With a proven track record of reducing hospital readmissions by 40% and ER visits by 16%, ConcertoCare is positioned at the intersection of value-based care and digital health innovation, addressing the systemic inefficiencies that often plague the management of high-risk patient cohorts.
How much funding has ConcertoCare raised?
ConcertoCare has raised a total of $188.1M across 6 funding rounds:
Private Equity
$15.4M
Debt
$7.2M
Debt
$15.2M
Private Equity
$15.2M
Private Equity
$30M
Series B
$105M
Private Equity (2012): $15.4M, investors not publicly disclosed
Debt (2013): $7.2M, investors not publicly disclosed
Debt (2013): $15.2M, investors not publicly disclosed
Private Equity (2015): $15.2M, investors not publicly disclosed
Private Equity (2016): $30M backed by Arboretum Ventures and Deerfield Management Company
Series B (2022): $105M with participation from The Obvious, Wells Fargo Capital Finance, Vast Ventures, Pennington Partners, Charles and Lynn Schusterman Family Foundation, Deerfield, and SteelSky Ventures
Key Investors in ConcertoCare
Deerfield Management
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy, supporting companies across the ecosystem with flexible funding models.
Arboretum Ventures
Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience, focusing on early-stage startups that aim to improve patient outcomes and reduce healthcare costs.
SteelSky Ventures
SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health, supporting innovations across digital health and infrastructure.
What's next for ConcertoCare?
With the successful closure of its latest funding round, ConcertoCare is poised to accelerate its market penetration and enhance its proprietary care delivery infrastructure. The strategic focus will likely center on scaling its multidisciplinary teams and integrating advanced data analytics to further refine its risk-stratification capabilities. As the healthcare industry continues to shift toward value-based reimbursement models, ConcertoCare's ability to demonstrate measurable clinical and financial outcomes provides a distinct competitive advantage. Future growth will likely involve expanding into new geographic territories and deepening partnerships with major health systems, ensuring that the company remains at the forefront of the movement to provide high-quality, cost-effective care to the populations that need it most.
See full ConcertoCare company page
